Proteomics

Dataset Information

0

Proteomic profiling of nuclear fractions of SMARCA4 knockdown samples in HDMB03


ABSTRACT: SMARCA4 mutations are common in Medulloblastoma but not much is understood about its pathobiology. In this study we prepared SMARCA4 knockdown models using a Group 3 medulloblastoma cell line called HDMB03 and investigated the proteomic changes. Nuclear enrichment was performed using hypertonic and hypotonic buffers. The nuclear enriched fractions were analysed on LC-MS/MS.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Prof. Sanjeeva Srivastava 

PROVIDER: PXD070641 | JPOST Repository | Wed Mar 25 00:00:00 GMT 2026

REPOSITORIES: jPOST

Dataset's files

Source:
Action DRS
O1_1.raw Raw
O1_2.raw Raw
O1_3.raw Raw
O2_1.raw Raw
O2_2.raw Raw
Items per page:
1 - 5 of 10
altmetric image

Publications

Quantitative DIA-MS Uncovers Functional Impact of SMARCA4 Knockdown in Group 3 Medulloblastoma.

Pai Medha Gayathri J MGJ   Singh Avinash A   Patra Sayan S   Narang Deepanshu D   Bapat Purna P   Bharambe Harish Shrikrishna HS   Shirsat Neelam N   Srivastava Sanjeeva S  

Journal of proteome research 20260326 5


Medulloblastoma, a pediatric brain tumor, frequently features chromatin modifier mutations, including SMARCA4 loss in the aggressive Group 3 subgroup. While SMARCA4 is considered a tumor suppressor, the functional impact of its loss on the oncogenic programs in Group 3 MB remains poorly understood. Using doxycycline-inducible shRNA constructs in HD-MB03 cells (a MYC-amplified Group MB model) to achieve SMARCA4 knockdown, we applied quantitative mass spectrometry to profile the resulting proteomi  ...[more]

Similar Datasets

2026-03-25 | PXD070640 | JPOST Repository
| PRJNA541844 | ENA
| PRJNA541853 | ENA
2019-07-23 | GSE121809 | GEO
2019-12-26 | GSE130870 | GEO
2019-12-26 | GSE130866 | GEO
| PRJNA498497 | ENA
2024-12-02 | PXD056036 | Pride
2016-04-21 | GSE76475 | GEO
2020-04-17 | GSE148799 | GEO